Hoffman was received by Abdullatif Almulla, CEO of TECOM Investments, Dr. Abdulqader Al Khayat, Executive Director of DuBiotech, and other senior officials.
Ashraf Allam, Director, Amgen MEA office, was also present at the meeting. Hoffman discussed future plans for Amgen at the biotech park, and highlighted latest industry breakthroughs.
The talks also covered DuBiotech's scientific research programmes and the new regulations as well as co-hosting of a scientific event in Dubai.
Amgen International's office at DuBiotech - the region's first free zone dedicated to biotechnology - manages all commercial operations in the Middle East and Africa (MEA) region.
Browse
related articles
Amgen International official visits DuBiotech
- United Arab Emirates: Tuesday, September 25 - 2007 at 11:16
- PRESS RELEASE
Related content
Rolf Hoffman, Senior Vice President - Commercial Operations, Amgen International, the world's largest biotechnology company, held discussions in Dubai with officials of Dubai Biotechnology and Research Park (DuBiotech), a member of TECOM Investments.
From Right: Abdullatif Almulla, CEO of TECOM Investments; Rolf Hoffman, Senior Vice President - Commercial Operations, Amgen International; Dr. Abdulqader Al Khayat, Executive Director of DuBiotech; Ashraf Allam, Director, Amgen MEA office.
Article Options
Log in to request more information from DuBiotech
Posted by Lara Lynn Golden, News EditorTuesday, September 25 - 2007 at 11:16 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Notes and Media Contacts »
About DuBiotech
Announced in February 2005, the Dubai Biotechnology and Research Park (DuBiotech) is a science and business park dedicated to the biotechnology industry, set within a 'free zone'. DuBiotech has two arms. The first is the Foundation for Research and Innovation (FRI) that will initially focus on government-funded R&D in medicine and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech and equine-related biotechnology. Other areas include drug discovery, stem cell research, infectious diseases and forensic research. The second arm of DuBiotech aims to set up a biotechnology industry cluster with cutting-edge infrastructure, facilities and services for incubators, R&D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organizations from other sectors in the industry. DuBiotech is advised by an independent steering committee on scientific, business and ethical matters. In cooperation with global research leader, RTI International, DuBiotech is developing comprehensive regulations that address all aspects of biotech activity. Being in a 'free zone' means biotechnology firms in the park have 100 % exemption from any form of taxation for 50 years, 100 % business ownership and 100 % repatriation of capital.
For further information, please call:
Zeba Ahmad
JiWiN
The Exclusive Middle East Affiliate of Burson-Marsteller
Tel: +9714 361 3590 (direct)
+9714 361 3333 (switchboard)
Fax: +9714 388 8001
Announced in February 2005, the Dubai Biotechnology and Research Park (DuBiotech) is a science and business park dedicated to the biotechnology industry, set within a 'free zone'. DuBiotech has two arms. The first is the Foundation for Research and Innovation (FRI) that will initially focus on government-funded R&D in medicine and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech and equine-related biotechnology. Other areas include drug discovery, stem cell research, infectious diseases and forensic research. The second arm of DuBiotech aims to set up a biotechnology industry cluster with cutting-edge infrastructure, facilities and services for incubators, R&D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organizations from other sectors in the industry. DuBiotech is advised by an independent steering committee on scientific, business and ethical matters. In cooperation with global research leader, RTI International, DuBiotech is developing comprehensive regulations that address all aspects of biotech activity. Being in a 'free zone' means biotechnology firms in the park have 100 % exemption from any form of taxation for 50 years, 100 % business ownership and 100 % repatriation of capital.
For further information, please call:
Zeba Ahmad
JiWiN
The Exclusive Middle East Affiliate of Burson-Marsteller
Tel: +9714 361 3590 (direct)
+9714 361 3333 (switchboard)
Fax: +9714 388 8001
Disclaimer »
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
